Los Angeles, CA3 Active Studies

Duchenne Muscular Dystrophy Clinical Trials in Los Angeles, CA

Find 3 actively recruiting duchenne muscular dystrophy clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
69
Enrolling

Recruiting Duchenne Muscular Dystrophy Studies in Los Angeles

About Duchenne Muscular Dystrophy Clinical Trials in Los Angeles

Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.

There are currently 3 duchenne muscular dystrophy clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 69 participants. Research is being sponsored by Solid Biosciences Inc., NS Pharma, Inc., Epicrispr Biotechnologies, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Duchenne Muscular Dystrophy Clinical Trials in Los Angeles — FAQ

Are there duchenne muscular dystrophy clinical trials in Los Angeles?

Yes, there are 3 duchenne muscular dystrophy clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What duchenne muscular dystrophy treatments are being tested?

The 3 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.

Data updated March 2, 2026 from ClinicalTrials.gov